Pascal Soriot says confidently that AstraZeneca will make its forecast of $45 billion in sales by 2023, the one it trotted out during its fight with Pfizer to convince shareholders it was best going it alone.
written on 04.06.2014
Smells like team spirit: AstraZeneca CEO says Pfizer fight has it pumped to perform
